An affordable, FDA-approved single-dose treatment for canine otitis externa
- Provides pricing flexibility to practices.
- Offers an affordable, effective otitis externa treatment option for dog owners.
- No at-home applications required.
- Convenient for veterinarians. Easy on dogs and dog owners.
Get Simplera today!
Simplera® is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).
IMPORTANT SAFETY INFORMATION:
CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. WARNINGS: Not for use in humans. Keep this and all drugs out of reach of children. Do not use in cats. In case of accidental skin contact, wash area thoroughly with water. Avoid contact with eyes. Humans with known hypersensitivity to florfenicol, terbinafine hydrochloride or mometasone furoate should not handle this product. PRECAUTIONS: Do not administer orally. Do not use in dogs with known tympanic membrane perforation. Reevaluate the dog if hearing loss or signs of vestibular dysfunction are observed during treatment. Use of topical otic corticosteroids has been associated with adrenocortical suppression and iatrogenic hyperadrenocorticism in dogs (see ANIMAL SAFETY on label). Use with caution in dogs with impaired hepatic function (see ANIMAL SAFETY on label). The safe use of Simplera in dogs used for breeding purposes, during pregnancy, or in lactating bitches has not been evaluated. For full prescribing information, visit www.vetoquinolusa.com/simplera-info.
© 2023 Vetoquinol USA, Inc. Vetoquinol, the Vetoquinol logo, and SIMPLERA are registered trademarks of Vetoquinol.
